Bharati R Dhruva
Examiner (ID: 3913)
Most Active Art Unit | 1632 |
Art Unit(s) | 1632 |
Total Applications | 2 |
Issued Applications | 1 |
Pending Applications | 1 |
Abandoned Applications | 0 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 6925372
[patent_doc_number] => 20050238627
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-10-27
[patent_title] => 'Methods and compositions for hybrid cell vaccines for the treatment and prevention of cancer'
[patent_app_type] => utility
[patent_app_number] => 11/071862
[patent_app_country] => US
[patent_app_date] => 2005-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 39938
[patent_no_of_claims] => 52
[patent_no_of_ind_claims] => 31
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0238/20050238627.pdf
[firstpage_image] =>[orig_patent_app_number] => 11071862
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/071862 | Methods and compositions for hybrid cell vaccines for the treatment and prevention of cancer | Mar 1, 2005 | Abandoned |
Array
(
[id] => 5894355
[patent_doc_number] => 20060002894
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-01-05
[patent_title] => 'Method for introducing a biological molecule using a viral envelope and composition and system therefor'
[patent_app_type] => utility
[patent_app_number] => 11/067109
[patent_app_country] => US
[patent_app_date] => 2005-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 18009
[patent_no_of_claims] => 72
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0002/20060002894.pdf
[firstpage_image] =>[orig_patent_app_number] => 11067109
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/067109 | Method for introducing a biological molecule using a viral envelope and heparin and system therefore | Feb 24, 2005 | Issued |
Array
(
[id] => 5726354
[patent_doc_number] => 20060057114
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-03-16
[patent_title] => 'Methods of using vectors to treat metabolic disorders'
[patent_app_type] => utility
[patent_app_number] => 11/057410
[patent_app_country] => US
[patent_app_date] => 2005-02-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 26068
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0057/20060057114.pdf
[firstpage_image] =>[orig_patent_app_number] => 11057410
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/057410 | Methods of treating lysosomal storage related diseases by gene therapy | Feb 13, 2005 | Issued |
Array
(
[id] => 6983856
[patent_doc_number] => 20050153926
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-07-14
[patent_title] => 'Method for the immobilization of oligonucleotides'
[patent_app_type] => utility
[patent_app_number] => 11/054650
[patent_app_country] => US
[patent_app_date] => 2005-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15321
[patent_no_of_claims] => 71
[patent_no_of_ind_claims] => 52
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0153/20050153926.pdf
[firstpage_image] =>[orig_patent_app_number] => 11054650
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/054650 | Method for the immobilization of oligonucleotides | Feb 8, 2005 | Abandoned |
Array
(
[id] => 5343487
[patent_doc_number] => 20090182137
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-07-16
[patent_title] => 'Vesicle for separating substances from liquid media'
[patent_app_type] => utility
[patent_app_number] => 10/588205
[patent_app_country] => US
[patent_app_date] => 2005-02-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 6560
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0182/20090182137.pdf
[firstpage_image] =>[orig_patent_app_number] => 10588205
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/588205 | Vesicle for separating substances from liquid media | Feb 1, 2005 | Abandoned |
Array
(
[id] => 8188400
[patent_doc_number] => 08182834
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-05-22
[patent_title] => 'Ternary non-lamellar lipid compositions'
[patent_app_type] => utility
[patent_app_number] => 10/586777
[patent_app_country] => US
[patent_app_date] => 2005-01-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 6
[patent_no_of_words] => 8860
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 134
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/182/08182834.pdf
[firstpage_image] =>[orig_patent_app_number] => 10586777
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/586777 | Ternary non-lamellar lipid compositions | Jan 20, 2005 | Issued |
Array
(
[id] => 5874030
[patent_doc_number] => 20060166220
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-07-27
[patent_title] => 'Chimeric tumor suppressor gene and protein'
[patent_app_type] => utility
[patent_app_number] => 11/040219
[patent_app_country] => US
[patent_app_date] => 2005-01-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 9302
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0166/20060166220.pdf
[firstpage_image] =>[orig_patent_app_number] => 11040219
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/040219 | Chimeric tumor suppressor gene and protein | Jan 20, 2005 | Issued |
Array
(
[id] => 8188400
[patent_doc_number] => 08182834
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-05-22
[patent_title] => 'Ternary non-lamellar lipid compositions'
[patent_app_type] => utility
[patent_app_number] => 10/586777
[patent_app_country] => US
[patent_app_date] => 2005-01-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 6
[patent_no_of_words] => 8860
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 134
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/182/08182834.pdf
[firstpage_image] =>[orig_patent_app_number] => 10586777
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/586777 | Ternary non-lamellar lipid compositions | Jan 20, 2005 | Issued |
Array
(
[id] => 13322
[patent_doc_number] => 07807426
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-10-05
[patent_title] => 'Processes for producing optically active 1-substituted 2-methylpyrrolidine'
[patent_app_type] => utility
[patent_app_number] => 10/586337
[patent_app_country] => US
[patent_app_date] => 2005-01-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5827
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/807/07807426.pdf
[firstpage_image] =>[orig_patent_app_number] => 10586337
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/586337 | Processes for producing optically active 1-substituted 2-methylpyrrolidine | Jan 18, 2005 | Issued |
Array
(
[id] => 5614391
[patent_doc_number] => 20060116319
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-01
[patent_title] => 'Method for identifying and treating photodamaged skin'
[patent_app_type] => utility
[patent_app_number] => 10/998685
[patent_app_country] => US
[patent_app_date] => 2004-11-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6129
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0116/20060116319.pdf
[firstpage_image] =>[orig_patent_app_number] => 10998685
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/998685 | Method for identifying and treating photodamaged skin | Nov 28, 2004 | Abandoned |
Array
(
[id] => 7097845
[patent_doc_number] => 20050130304
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-16
[patent_title] => 'Regulation of endogenous gene expression in cells using zinc finger proteins'
[patent_app_type] => utility
[patent_app_number] => 10/986583
[patent_app_country] => US
[patent_app_date] => 2004-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 29754
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0130/20050130304.pdf
[firstpage_image] =>[orig_patent_app_number] => 10986583
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/986583 | Regulation of endogenous gene expression in cells using zinc finger proteins | Nov 11, 2004 | Abandoned |
Array
(
[id] => 5045607
[patent_doc_number] => 20070264280
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-11-15
[patent_title] => 'Compositions and Methods for Treating Neurological Diseases'
[patent_app_type] => utility
[patent_app_number] => 10/578561
[patent_app_country] => US
[patent_app_date] => 2004-11-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 16656
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0264/20070264280.pdf
[firstpage_image] =>[orig_patent_app_number] => 10578561
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/578561 | Compositions and Methods for Treating Neurological Diseases | Nov 7, 2004 | Abandoned |
Array
(
[id] => 8114409
[patent_doc_number] => 08158420
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-04-17
[patent_title] => 'Methods for inhibiting the differentation of proliferative telencephalic cells in vitro by addition of ATF5'
[patent_app_type] => utility
[patent_app_number] => 10/971483
[patent_app_country] => US
[patent_app_date] => 2004-10-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 34625
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/158/08158420.pdf
[firstpage_image] =>[orig_patent_app_number] => 10971483
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/971483 | Methods for inhibiting the differentation of proliferative telencephalic cells in vitro by addition of ATF5 | Oct 21, 2004 | Issued |
Array
(
[id] => 7811169
[patent_doc_number] => 08133699
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-03-13
[patent_title] => 'Minimal DNA sequence acting as a chromatin insulator and its use in protein expression'
[patent_app_type] => utility
[patent_app_number] => 10/576509
[patent_app_country] => US
[patent_app_date] => 2004-10-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 5
[patent_no_of_words] => 6511
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/133/08133699.pdf
[firstpage_image] =>[orig_patent_app_number] => 10576509
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/576509 | Minimal DNA sequence acting as a chromatin insulator and its use in protein expression | Oct 19, 2004 | Issued |
Array
(
[id] => 92236
[patent_doc_number] => 07732420
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-06-08
[patent_title] => 'Combinations of transfection lipids exhibiting increased transfection efficiencies'
[patent_app_type] => utility
[patent_app_number] => 10/957977
[patent_app_country] => US
[patent_app_date] => 2004-10-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 10058
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/732/07732420.pdf
[firstpage_image] =>[orig_patent_app_number] => 10957977
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/957977 | Combinations of transfection lipids exhibiting increased transfection efficiencies | Oct 3, 2004 | Issued |
Array
(
[id] => 92236
[patent_doc_number] => 07732420
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-06-08
[patent_title] => 'Combinations of transfection lipids exhibiting increased transfection efficiencies'
[patent_app_type] => utility
[patent_app_number] => 10/957977
[patent_app_country] => US
[patent_app_date] => 2004-10-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 10058
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/732/07732420.pdf
[firstpage_image] =>[orig_patent_app_number] => 10957977
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/957977 | Combinations of transfection lipids exhibiting increased transfection efficiencies | Oct 3, 2004 | Issued |
Array
(
[id] => 5153838
[patent_doc_number] => 20070036721
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-02-15
[patent_title] => 'Methods and compositions for in vivo inflammation monitoring'
[patent_app_type] => utility
[patent_app_number] => 10/572732
[patent_app_country] => US
[patent_app_date] => 2004-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 61
[patent_figures_cnt] => 61
[patent_no_of_words] => 49777
[patent_no_of_claims] => 151
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0036/20070036721.pdf
[firstpage_image] =>[orig_patent_app_number] => 10572732
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/572732 | Methods and compositions for in vivo inflammation monitoring | Sep 22, 2004 | Abandoned |
10/935709 | Novel murine polynucleotide sequences and mutant cells and mutant animals defined thereby | Sep 6, 2004 | Abandoned |
Array
(
[id] => 7154163
[patent_doc_number] => 20050026201
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-02-03
[patent_title] => 'Method of modulating or examining Ku70 levels in cells'
[patent_app_type] => utility
[patent_app_number] => 10/924060
[patent_app_country] => US
[patent_app_date] => 2004-08-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 15858
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0026/20050026201.pdf
[firstpage_image] =>[orig_patent_app_number] => 10924060
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/924060 | Method of modulating or examining Ku70 levels in cells | Aug 22, 2004 | Abandoned |
Array
(
[id] => 7329858
[patent_doc_number] => 20040254134
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-16
[patent_title] => 'Biological pacemaker'
[patent_app_type] => new
[patent_app_number] => 10/476259
[patent_app_country] => US
[patent_app_date] => 2004-08-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 32
[patent_no_of_words] => 14647
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 3
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0254/20040254134.pdf
[firstpage_image] =>[orig_patent_app_number] => 10476259
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/476259 | Biological pacemaker | Aug 9, 2004 | Abandoned |